58 related articles for article (PubMed ID: 16863517)
1. Successful treatment of Behçet's disease ulcers and skin lesions with hydrogen water.
Guan C; Zhang Z; Wang L; Chen SA; Luo X
Int J Dermatol; 2024 Mar; 63(3):379-380. PubMed ID: 38284276
[No Abstract] [Full Text] [Related]
2. Correction to: Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach.
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38498848
[No Abstract] [Full Text] [Related]
3. Behçet's syndrome: a critical digest of the 2013-2014 literature.
Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S112-22. PubMed ID: 25268667
[TBL] [Abstract][Full Text] [Related]
4. High mobility group box-1 levels may be associated with disease activity of Behcet's disease.
Güler DD; Keleşoğlu Dinçer AB; Karahan ZC; Güler HS; Yayla ME; Sezer S; Aydemir Gülöksüz EG; Okatan İE; Torgutalp M; Eroğlu DŞ; Yüksel ML; Turgay TM; Kınıklı G; Ateş A
Turk J Med Sci; 2021 Oct; 51(5):2690-2697. PubMed ID: 34333900
[TBL] [Abstract][Full Text] [Related]
5. Mucocutaneous Manifestations of Behçet's Disease.
Nakamura K; Tsunemi Y; Kaneko F; Alpsoy E
Front Med (Lausanne); 2020; 7():613432. PubMed ID: 33598466
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease: recent advances in early diagnosis and effective treatment.
Calamia KT; Kaklamanis PG
Curr Rheumatol Rep; 2008 Oct; 10(5):349-55. PubMed ID: 18817637
[TBL] [Abstract][Full Text] [Related]
7. Behçet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease.
Akay N; Boyvat A; Heper AO; Soykan I; Arica IE; Bektas M; Ensari A; Cokca F
Clin Exp Dermatol; 2006 May; 31(3):384-6. PubMed ID: 16681583
[TBL] [Abstract][Full Text] [Related]
8. Dermatologic manifestation of Behçet's disease.
Lee ES; Bang D; Lee S
Yonsei Med J; 1997 Dec; 38(6):380-9. PubMed ID: 9509907
[TBL] [Abstract][Full Text] [Related]
9. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease?
Kalkan G; Karadag AS; Astarci HM; Akbay G; Ustun H; Eksioglu M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1056-60. PubMed ID: 19453803
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic and direct immunofluorescence findings of the papulopustular lesions in Behçet's disease.
Ilknur T; Pabuççuoglu U; Akin C; Lebe B; Gunes AT
Eur J Dermatol; 2006; 16(2):146-50. PubMed ID: 16581565
[TBL] [Abstract][Full Text] [Related]
11. Histopathological and clinical evaluation of papulopustular lesions in Behçet's disease.
Kutlubay Z; Mat CM; Aydin Ö; Demirkesen C; Calay Ö; Engın B; Tüzün Y; Yazici H
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S101-6. PubMed ID: 26344806
[TBL] [Abstract][Full Text] [Related]
12. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
Bariş YS; Yildiz L; Sentürk N; Kandemir B
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
[TBL] [Abstract][Full Text] [Related]
13. Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behçet's disease.
Alpsoy E; Uzun S; Akman A; Acar MA; Memişoglu HR; Başaran E
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):521-4. PubMed ID: 12941085
[TBL] [Abstract][Full Text] [Related]
14. Can specific vessel-based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular-based lesions clinically?
Boyvat A; Heper AO; Koçyiğit P; Erekul S; Gürgey E
Int J Dermatol; 2006 Jul; 45(7):814-8. PubMed ID: 16863517
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
